Skip to search boxSkip to navigationSkip to main content

A high-throughput population screening system for the estimation of genetic risk for type 1 diabetes: An application for the TEDDY (The Environmental Determinants of Diabetes in the Young) study

  • Minna Kiviniemi(corresponding author)
    ,
  • Robert Hermann
    ,
  • Jussi Nurmi
    ,
  • Anette G. Ziegler
    ,
  • Mikael Knip
    ,
  • Olli Simell
*Corresponding author for this work
  • University of Turku
    ,
  • Abacus Diagnostica Ltd.
    ,
  • Diabetes Research Institute
    ,
  • Klinikum Bogenhausen
    ,
  • University of Helsinki
    ,
  • Tampere University
Scholary Output:
Contribution to journal
Article
Research
Peer-review

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

Background: In the TEDDY (The Environmental Determinants of Diabetes in the Young) study patient eligibility is based on the presence of some selected type 1 diabetes risk-associated human leukocyte antigen DR-DQ genotypes. A practical screening strategy was needed with efficient exclusion of ineligible patients at an early stage. Also, a simple, low-cost, and fast screening system was essential for the primary step of the risk assessment including thousands of samples. Methods: A homogeneous genotyping system utilizing an asymmetric polymerase chain reaction (PCR) and subsequent hybridization of allele-specific probes was designed to be used as the first screening step. This assay was combined with methods further elucidating the genetic risk of type 1 diabetes to screen for high-risk individuals. Results: The homogeneous assay platform allows the typing of hundreds of samples within one working day. The costs of the assay are minimal, and the reduction in hands-on time provides considerable improvements compared to the heterogeneous genotyping methods comprising separate PCR and hybridization steps. The primary selection criteria used in the first step proved to be efficient since the numbers of samples typed in subsequent stages were markedly reduced. Conclusions: The presented assay system provides a practical approach to the rapid screening of thousands of samples at low cost, a general starting point for large-scale screening studies.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Research
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 460-472 (13 pages)

Journal (Volume, Issue Number)

Diabetes Technology and Therapeutics (Volume 9, Issue 5)

Publication milestones

  • Published - 10/01/2007

Publication status

Published - 10/01/2007

ISSN

1520-9156

Publication IDs

  • Scopus: 35348853966
  • PubMed: 17931054
  • ORCID: /0000-0002-3040-3631/work/227033615

Publication metrics

Metrics

Scopus
citations
SciVal
citations
46
SciVal
FWCI
0.93
SciVal
Author count
108
SciVal
Paper percentile
87
Fractional count
2
Fractional count
0.02
Fractional count
106
Fractional count
0.98
Fractional count
2
Fractional count
1

PlumX, opens in new tab

Captures
39
Citation count
69

Funding Details

FunderFunding number
NIDDK
U01DK063865